FDA rejects Chiasma's drug to treat growth disorder

The U.S. Food and Drug Administration has rejected Chiasma Inc's experimental drug to treat adults with acromegaly, the company said on Friday. Reuters
Source: Society for Endocrinology - Category: Endocrinology Source Type: news